3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
7
Carcinoma, Hepatocellular
6
Sarcoma
2
Rectal Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Gastrointestinal Stromal Tumors
2
Solid Malignant Tumors
1
Sarcoma, Ewing
1
Recurrence
1
Piebaldism
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Liver Metastasis Colon Cancer
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Disease Progression
1
Cholangiocarcinoma
1
Bone Neoplasms
1
Interventions
Cisplatin
15
Gemcitabine
14
durvalumab
10
pembrolizumab
7
Oxaliplatin
6
Bevacizumab
6
Capecitabine
5
lenvatinib
4
Nivolumab
4
S 1 (combination)
3
Liquid Biopsy
3
Irinotecan
3
Folfox protocol
3
Fluorouracil
3
Carboplatin
3
zanidatamab
2
tremelimumab
2
envafolimab
2
Trastuzumab
2
Leucovorin
2
Injections
2
Blood Specimen Collection
2
Albumin-Bound Paclitaxel
2
trastuzumab deruxtecan
1
toripalimab
1
tislelizumab
1
poly ICLC
1
niraparib
1
neratinib
1
larotrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
regorafenib
×
90 days
×
Clear all
No trials found.